GI Dynamics - EndoBarrier Patient Testimonial Video
GID
Fri, 10 Nov 2017, 12:30 GMT
GI Dynamics, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device approved for the treatment of type 2 diabetes and obesity.
Industry: Health Care
Contact:
A summary of views and experience of the patients who were treated with EndoBarrier under Dr Ryder.
